Akebia John Butler
From Akebia, Trading M&A For an IPO, Follows Fast in Anemia Drug Race:
John Butler, CEO of Akebia Therapeutics
From Akebia, Trading M&A For an IPO, Follows Fast in Anemia Drug Race:
John Butler, CEO of Akebia Therapeutics
Comments are closed.